|
Volumn 26, Issue 4, 2000, Pages 133-138
|
Evaluation of the effects of zafirlukast 40 MG B.I.D. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: Preliminary data
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE;
CORTICOSTEROID;
FLUNISOLIDE;
ZAFIRLUKAST;
ABDOMINAL PAIN;
ADD ON THERAPY;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DISEASE EXACERBATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
HYPEREOSINOPHILIA;
LUNG FUNCTION;
MALE;
PATIENT COMPLIANCE;
PEAK EXPIRATORY FLOW;
SYMPTOMATOLOGY;
ADMINISTRATION, INHALATION;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADRENERGIC BETA-AGONISTS;
ADULT;
AGED;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
CHILD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMANS;
MALE;
MIDDLE AGED;
TOSYL COMPOUNDS;
|
EID: 0033710482
PISSN: 03786501
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (21)
|